Australian Clinical Labs Limited (ASX:ACL)
Australia
· Delayed Price · Currency is AUD 3.010
+0.060 (2.03%)
Apr 24, 2025, 4:10 PM AEST
Australian Clinical Labs Revenue
Australian Clinical Labs had revenue of 369.17M AUD in the half year ending December 31, 2024, with 2.46% growth. This brings the company's revenue in the last twelve months to 728.27M, up 8.05% year-over-year. In the fiscal year ending June 30, 2024, Australian Clinical Labs had annual revenue of 696.37M, down -0.10%.
Revenue (ttm)
728.27M
Revenue Growth
+8.05%
P/S Ratio
0.81
Revenue / Employee
148.63K
Employees
4,900
Market Cap
593.34M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |